Evidence map›Paper›PMID 42315615›Full record

ArticleNPJ digital medicine2026

Unlocking multi-institutional insights into disease progression with PEAL as a lossless, one-shot federated learning solution.

Yicheng Shen, Ji Soo Kim, Chongliang Luo, Scott L Zeger, Robyn T Domsic, Ami A Shah, Jiayi Tong

Abstract read
In one paragraph

Article in NPJ digital medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Yicheng ShenDepartment of Biostatistics, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA.
Ji Soo KimDepartment of Biostatistics, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA.
Chongliang LuoDivision of Public Health Sciences, Washington University School of Medicine, St. Louis, MO, USA.
Scott L ZegerDepartment of Biostatistics, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA.
Robyn T DomsicDivision of Rheumatology and Clinical Immunology, University of Pittsburgh Medical Center, Pittsburgh, PA, USA.
Ami A ShahDivision of Rheumatology, Johns Hopkins School of Medicine, Baltimore, MD, USA.
Jiayi TongDepartment of Biostatistics, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA. jtong@jhu.edu.

Funding

Sample Processing and Immunoassay Research CoreP30AR070254 · NIAMS · JOHNS HOPKINS UNIVERSITY · PI Antony Rosen · 2016 to 2026
$8.9M
Harnessing multivariate patient- and population-level disease trajectories to predict major clinical events in sclerodermaK24AR080217 · NIAMS · JOHNS HOPKINS UNIVERSITY · PI Ami Aalok Shah · 2022 to 2026
$847k
NIAMS NIH HHS K24 AR080217NIAMS NIH HHS P30 AR070254the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)/National Institutes of Health (NIH) P30 AR070254
6 · The paper itself

Abstract

Multisite analysis of electronic health record (EHR) data presents unique opportunities for studying disease progression in real-world settings. However, privacy concerns, communication costs, and site-level heterogeneity pose significant challenges for analyzing longitudinal data. We introduce PEAL (Privacy-preserving Efficient Aggregation for Longitudinal data), a novel federated learning algorithm for fitting multi-level linear mixed-effects models with spline basis terms for nonlinear temporal trends. PEAL requires only a single-round transfer of summary statistics and produces results identical to using pooled individual participant data. Simulation studies demonstrate that PEAL accurately recovers fixed effects and variance components under realistic multi-level structures. We applied PEAL to real-world longitudinal datasets of systemic sclerosis patients from the Johns Hopkins and University of Pittsburgh Scleroderma Centers. This application shows our algorithm captures reasonable disease trajectories. Overall, PEAL provides a practical solution for distributed research networks studying rare diseases and time-evolving clinical outcomes by enabling lossless, communication-efficient, and privacy-preserving modeling.

Identifiers

PMID42315615
PMCPMC13639078

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.